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Abstract In higher eukaryotic genomes, methylated cytosine 
residues (mSC) are distributed in heritable, cell-type-specific 
patterns, which are believed to be involved in the control of gene 
expression, developmental regulation and genomic imprinting. 
These methylation patterns are estabfished and maintained by 
DNA cytosine-5 methyltransferase (MTase), a ~ 1500 amino 
acid enzyme containing a regulatory N-terminal domain and a 
catalytic C-terminal domain. The mechanism responsible for 
targeting MTase to particular genes is poorly understood and 
might possibly involve interactions with other proteins. In an 
effort to identify proteins that interact with the mammalian 
MTase, we used the yeast two-hybrid system with several 
different MTase domains as baits. Here we report an interaction 
between the C-terminal catalytic domain of the MTase and p23, 
a protein previously reported to associate with the progesterone 
receptor (PR) complex. 
Key words: Mammalian DNA cytosine-5 methyltransferase; 
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1. Introduction 
Methylated cytosine residues (mSC) are distributed in heri- 
t~Lble, tissue-type-specific manners in higher eukaryotic gen- 
o,nes. These cytosine methylation patterns have been impli- 
c:.~ted in the control of gene transcription, development and 
gcnomic imprinting in mammals [1-5]. DNA cytosine-5 
MTase is the enzyme believed to be primarily responsible 
f i r  establishing and propagating the methylation patterns 
tl rough cell generations [6]. Consistent with this notion, tar- 
g~;ted isruption of the MTase gene in the mouse results in 
embryonic lethality [7]. The mammalian MTase protein con- 
t~ins an N-terminal domain of about 1000 amino acids, which 
h ~s no counterpart in the bacterial enzymes, in addition to a 
(-terminal 500 amino acid domain that is closely related to 
b~cterial cytosine-5 MTases [8]. Contained within the N-term- 
inal domain are several putative sub-domains, including a 
(ys-rich region [9] and a targeting sequence that mediates 
tte association of DNA MTase with the replication apparatus 
daring S-phase [10]. The C-terminal domain contains residues 
t tat are essential for sequence specific recognition of DNA 
aad for catalysis of methyl transfer. Mammalian MTase op- 
e "ates preferentially on hemimethylated DNA, thus ensuring 
ti~e clonal propagation of cell-type-specific methylation pat- 
t~:rns during cell division. Proteolysis, which leaves the C- 
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terminal domain intact but cleaves the N-terminal domain 
into smaller fragments, greatly stimulates the enzyme's de 
novo activity on unmethylated substrates [11], suggesting 
that N-terminal domain can modulate the specificity of the 
C-terminal catalytic domain. The mechanism underlying this 
regulatory effect is not known, nor is it understood how the 
enzyme is targeted to certain genes during embryonic devel- 
opment. 
One possible mechanism for recruitment of MTase to cer- 
tain genes might involve direct interactions with other pro- 
teins, by analogy to the process of transcription i itiation in 
eukaryotes [12,13]. A well-defined segment of the N-terminal 
domain is responsible for targeting the MTase to replication 
foci, most likely through protein-protein i teractions. To 
identify potential interacting proteins of MTase, we utilized 
two-hybrid screening assays in yeast [14,15]. Several segments 
of the MTase N-terminal domain, including the replication 
targeting domain, themselves activate transcription when 
fused to the LexA DNA-binding domain, which precluded 
two-hybrid screening using these segments. No interacting 
proteins for the Cys-rich region were identified. However, 
the C-terminal catalytic domain of the MTase was found to 
associate with the p23 protein, best known for its association 
with the cytoplasmic form of the progesterone r ceptor. In 
vitro binding assays confirmed that p23 and MTase interact 
specifically, and the results of co-immunoprecipitation experi- 
ments provide evidence that the two can associate in vivo. 
2. Materials and methods 
2.1. Plasmids 
Four different regions of human MTase [16] were PCR-amplified by 
pfu polymerase (Stratagene) from pBSHMT (gift from Dr. S. Baylin, 
Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA) 
using primers that included on their ends either an EcoRI (N-terminal 
primer) or SalI (C-terminal primer) site. The PCR product was re- 
stricted with EcoRI and SalI and cloned into the vector pEG202 [15] 
to generate baits having residues 1-147 of the LexA DNA-binding 
domain fused at its C-terminus to various regions of MTase: pLexA- 
hMT(207~55), pLexA-hMT(529-607), pLexA-hMT(608-1004) and 
pLexA-hMT(999-1495):Cl105A (contains an active site Cys to Ala 
mutation). Both pRFHM1 (LexA DNA-binding domain fused to 
Drosophila bicoid protein) and a HeLa cDNA library tagged with 
the B42 activation domain were kindly provided by Dr. R. Brent 
(Harvard Medical School, Boston, MA 02114, USA). 
The full-length mouse MTase cDNA (gift from Dr. T. Bestor, Co- 
lumbia University, New York, USA) was equipped with 6 x His and 
Myc epitope (EQKLISEEDL) tags at the N-terminus, cloned into the 
mammalian expression vector pEVRF0 [17] between KpnI and XbaI 
sites to generate p(His)6Myc-mMT. The p23 protein was expressed as 
a glutathione S-transferase (GST) fusion protein using a Pharmacia 
pGEX-5X vector. All constructs were verified by dideoxy sequencing. 
Abbreviations: MTase, mammalian DNA cytosine-5 methyltransfer- 
ase; GST, glutathione S-transferase; X-Gal, 5-bromo-4-chloro-2- 
indolyl [3-o-galactoside; MEL, murine erythroleukemia cell; PR, 
progesterone r ceptor 
2.2. Two-hybrid assays 
The yeast selection strain EGY48 and lacZ reporter were used as 
described [18,19]. Cells were transformed with both LexA DNA-bind- 
ing domain fusion baits and B42 activation domain fusion library by 
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the lithium acetate method. The transformation mixtures were plated 
on appropriate selective synthetic media. To represent adequately the 
complexity of the cDNA library, we obtained 5 X 106 primary trans- 
formants. After 3 days at 30°C, these transformants were harvested 
and mixed thoroughly as a pool. About 5 x l0 T colony forming units 
(cfu) from this pool were induced with galactose to drive the library 
protein expression and then plated on media lacking leucine for LEU2 
reporter selection. All the colonies appearing after 4 days were subject 
to 5-bromo-4-chloro-2-indolyl I]-D-galactoside (X-Gal) filter assays for 
lacZ reporter expression. Only those LEU2 and lacZ double-positive 
colonies were picked up and assayed again to confirm their galactose- 
dependent expressions of LEU2 and lacZ reporters. 
2.3. GST fusion protein binding assays 
pGEX5X-p23 was transformed into E. coli strain BL21 and a mid- 
log phase cell culture was induced with 1 mM isopropyl I]-D-thioga- 
lactoside (IPTG) and grown for 4 h at 37°C. Cell lysates were then 
loaded on a glutathione-agarose column which was subsequently 
washed 3 times with PBS. MEL cell nuclear extracts or 50% pure 
Myc-tagged mouse MTase were passed through minicolumns pre- 
packed with GST-p23 bound resin or GST bound resin. These resins 
were then washed 3 times with 1 of ml buffer containing 50 mM Tris- 
HC1, pH 8.0, 100 mM NaC1, 10% glycerol, and subsequently sus- 
pended in SDS sample buffer and analyzed by immunoblotting with 
anti-pATH52 or anti-Myc antibody 9El0. 
2.4. Co-immunoprecipitation 
Nuclear extracts of Friend murine erythroleukemia (MEL) cells 
were made following procedures described by Roeder et al. [20]. 
The polyclonal rabbit anti-mouse MTase antibody anti-pATH52 
[11] was a gift from Dr. T. Bestor. The monoclonal anti-p23 anti- 
bodies JJ3 and JJ5 [21] were generously provided by Dr. D. Toft 
(Mayo Graduate School, Rochester, MN 55905, USA). MEL nuclear 
extracts (1 ml) were precleared with 20 lal of preimmune rabbit serum 
or an unrelated monoclonal antibody followed by incubation with 25 
~tl of protein A positive S. aureus cell pellet. After centrifugation, 4 ktl 
of anti-pATH52 or 15 /.tl of JJ3 was added to the supernatant fol- 
lowed by shaking at 4°C for 1 h. Mock immunoprecipitation co trols 
were run without addition of antibody. Fifty microliters of slurry of 
50% protein A-Sepharose resin (Pharmacia) was then added to the 
mixture followed by shaking for another 1 h. The resin was pelleted 
and washed 4 times with washing buffer (20 mM Hepes, pH 7.9, 150 
mM NaC1, 0.1% Triton X-100) with subsequent resuspension i SDS 
buffer. The samples were denatured by boiling for 5 min and analyzed 
on SDS-PAGE gel. Proteins were visualized by silver staining and/or 
Western blot analysis. 
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2.5. Mammalian expression and purification of Myc-tagged mouse 
MTase 
COS-7 cells were transfected with p(His)6Myc-mMT using DEAE- 
DEXTRAN methods [10]. After 48 h, the COS cells were harvested by 
trypsination and lysed in 5 vol of lysis buffer (20 mM HEPES, pH 7.9, 
20% glycerol, 0.3% Triton X-100, 0.4 M NaCI, 1 mM DTT, 1 mM 
PMSF, 2 ~tg/ml of each aprotinin, pepstatin A, leupeptin, benzami- 
dine). The lysate was incubated with Ni 2÷ NTA-resin at 4°C followed 
by elution of the Myc-tagged mouse MTase with a linear gradient of 
imidazole (0.8-300 mM). The recombinant MTase was purified to 
50% homogeneity upon elution with 40-80 mM imidazole. 
3. Results 
3.1. Two regions o f  human MTase can be used as baits 
Constructs containing four different regions of the fused to 
the DNA-binding domain of LexA were generated as poten- 
tial 'baits' for two-hybrid screening (Fig. 1). The MTase re- 
gions chosen for study are the replication-targeting sequence 
(207-455); a Cys-rich motif  (529~07) related to that in the 
human trithorax homologue, HRX/ALL-1 [9]; a large region 
of unknown function located between the Cys-rich and cata- 
lytic domain (608-1004); and the entire C-terminal catalytic 
domain (999-1495). To avoid complexity that might arise 
through the methylation of yeast DNA by fusing the MTase 
catalytic domain to LexA, we mutated an essential catalytic 
residue, Cysl l05, to Ala. In the context of the full-length 
MTase protein, the C l l05A mutation abrogates catalysis 
but leaves intact the ability of the protein to bind DNA 
(X.Z. and G.L.V., unpublished results). Similar observations 
have been reported with the bacterial homologues of the hu- 
man MTase [22,23]. Baits I - IV were first tested for their abil- 
ity to activate the transcription of lacZ and LEU2 reporter 
constructs, each driven by multiple LexA operators. As shown 
in Fig. 1, baits I and III by themselves trongly activated 
reporter gene transcription, and thus were unsuitable for use 
in two-hybrid screening. 
On the other hand, baits II and IV showed no detectable 
reporter gene activation. Repression assays confirmed that the 
bait II and IV fusion proteins enter the yeast nucleus and bind 
Catalytic Domain 
CllO5->A 
I II I I I  IV 
(207- 455) (529-607) (607-1004) (999-1495) 
~Gal Activity: +++ -- ++ 
Repression Assay: N.D. + N.D. + 
Full Length Protein 
Expressed in Yeast: N.D. + N.D. + 
Fig. 1. Bait constructs and activity tests. Baits I and III activated reporter gene transcription and hence were not studied further. Baits II and 
IV exhibited the least levels of 13-galactosidase activity and therefore were analyzed in repression assays. A (+) repression assay result indicates 
that the bait construct is capable of entering the yeast nucleus and binding to the reporter gene. Both baits II and IV were expressed in yeast 
as full-length fusion proteins, as determined by Western blotting using an anti-LexA antibody (data not shown). N.D. : not determined. 
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Table 1 
~-Galactosidase ctivities of positive clones from two hybrid screens 
18l 
B42 activation LexA DNA-binding domain fusion 
comain fusion hMTase(529-607)  hMTase(999-1495) Bicoid ORF (aa) 
Clone 1 - ++ +/- 177 
Clone 2 - ++ +/- 175 
Clone 3 - ++ +/- 177 
The yeast reporter strain EGY 48 was transformed with the indicated LexA DNA-binding domain and B42 activation domain fusion plasmids and 
piated on selective synthetic medium. The expression of I~-galactosidase wasmonitored by using the assays described inSection 2and scored on a 
st ale of - to ++ according to the rate at which blue color developed. The positive clones were sequenced to identify the open reading frames (ORF) 
o the non-LexA derived portions of the fusion constructs. 
t,, LexA operators (Fig. 1). Immunoblotting of yeast cell ex- 
tiacts using a polyclonal antibody directed against LexA ver- 
il:ed the expression of the full-length LexA-fusion baits II and 
l ' !  proteins. Therefore, baits II and IV were deemed suitable 
f,,r use in two-hybrid screening. 
3 2. Recovery of the p23 from a two-hybrid screen 
We used the yeast wo-hybrid system as modified by Brent 
a ad colleagues (interaction trap) [15,19] to identify proteins 
i~teracting with domains II and IV of the human MTase. Bait 
c,mstructs II and IV were separately used to screen a human 
t :eLa cDNA library in which the inserts were expressed as 
f,tsions to the E. coli B42 activation domain [15]. A yeast 
s~rain bearing integrated LEU2 and extrachromosomal l cZ 
r~;porters was transformed with either the bait II or IV-encod- 
i~g plasmid and the B42 fusion cDNA library to generate 
,-~ 5)< 106 independent transformants. Cells harboring candi- 
c ate MTase interactors were identified by their ability to grow 
~n media lacking leucine and to turn blue on X-Gal impreg- 
r~ated filters upon induction by galactose. The roughly 100 
91onies from baits II and IV that passed this initial selection 
~ere patched to glucose media to silence the expression of 
1 brary proteins, then replica-plated to four different selection 
rledia (Leu /Gal, Leu /Glu, X-Gal/Gal, X-Gal/Glu) to test 
whether the activation of LEU2 and lacZ reporter genes were 
~ependent on galactose induced library protein expressions. 
t inally, positive library plasmids were isolated from 36 bait 
l[ colonies and 25 bait IV colonies, retransformed into the 
t arent yeast reporter strain with either the original bait plas- 
nuclear 
load" ext ract MTase 
I I I I 
GST- GST-  
resin" GST p23 p23 
MTase 
t'ig. 2. p23 specific binding by MTase in vitro. Partially purified 
Myc-tagged MTase or MEL nuclear extract were loaded to glu- 
tathione-agarose columns containing either bound GST or GST- 
p23. After washing, the resin bound proteins were fractionated by 
SDS-PAGE, blotted and probed for the presence of MTase using 
an anti-MTase antibody (anti-pATH52). 
mid or unrelated bait plasmid pRFHM 1 (LexA-bicoid fusion 
construct). In this tertiary screen, none of the library clones 
screened using bait II scored positive for plasmid linkage of 
reporter gene activation. However, 10 of the 25 library clones 
screened using bait IV were able to activate reporter gene 
activation in the presence of bait IV; none of these strongly 
activated the reporters in the presence of bait II or the control 
LexA-bicoid fusion construct. Interestingly, the inserts of all 
10 plasmids had a similar size (,~ 1.5 kb) and yielded almost 
identical restriction patterns upon cleavage by AluI or HaelII 
(data not shown). Sequencing of the inserts in 3 out of 10 
clones revealed that they possess a virtually identical open 
reading frame of around 175 amino acids. A search against 
the GenBank nucleic acid sequence database indicated that 
the clones are identical to the human p23 cDNA[21]. Se- 
quences 45 to 51 nucleotides upstream of the p23 start codon 
were also included in these clones, resulting the addition of 15 
to 17 residues between the LexA DNA-binding domain and 
the full-length p23 protein (Table 1). 
3.3. Binding of the MTase to p23 in vitro 
p23, so named for its apparent molecular weight on SDS- 
PAGE gels, is an ~ 18 kDa protein of wide tissue distribu- 
tion, which is highly conserved throughout eukaryotes, p23 
was first observed as a component of the cytoplasmic form 
of the avian progesterone r ceptor (PR) complex [24], but it 
has also been found associated with the 90 kDa heat shock 
protein, hsp90 [25]. 
To determine if MTase and p23 interact directly independ- 
ent of any yeast bridging proteins, a GST-fusion protein was 
expressed containing the full-length p23. The bacterially over- 
produced GST-p23 or GST control were purified on glu- 
tathione agarose and then incubated with MEL nuclear ex- 
tract or purified mouse MTase. Bound MTase were detected 
by immunoblotting with anti-MTase (Fig. 2). As shown, 
GST-p23 could bind to both purified mouse MTase and en- 
dogenous MTase in MEL nuclear extract. As a control, GST 
alone did not bind to MTase detectably. This in vitro binding 
assay provides evidence that MTase and p23 can interact di- 
rectly. 
3.4. Association of MTase with p23 in MEL cells 
To compare the tissue distribution of p23 with that of the 
MTase, we carried out Western blot analysis using nuclear 
and cytoplasmic extracts of murine erythroleukemia (MEL) 
cells (Fig. 3). As previously observed [10], the MTase is loca- 
lized primarily in the nucleus (Fig. 3A). p23 is also found in 
the nucleus, but is equally distributed in the cytoplasm of 
MEL cells (Fig. 3B). To assess the interaction of p23 and 
182 
A B 
1 2 1 2 
41- -MTase  4p-p23  
Fig. 3. Distribution of MTase and p23 in MEL cytosol and nuclear 
extract. A: MTase is a nuclear protein. MEL cytosol (C) and nucle- 
ar extract (N) each 10 /.tl was run on a 5% SDS-PAGE gel, trans- 
ferred to nitrocellulose membrane and blotted with mouse MTase 
antiserum anti-pATH52. B: Similar levels of p23 were detected in 
MEL cytosol and nuclear extract. Equal amount (10 I.tl) of MEL 
cytosol and nuclear extract from the same preparation as above 
were blotted with p23 antibody J J3. 
the MTase in vivo, we used a polyclonal antibody (anti- 
pATH52) that targets the N-terminal domain of the mouse 
MTase to immunoprecipitate MEL cell nuclear extracts, then 
analyzed the interacting proteins by SDS-PAGE (Fig. 4A) 
and Western blotting using monoclonal anti-p23 antibodies 
(Fig. 4B). Anti-pATH52 precipitated a band having a mole- 
cular mass of 23 kDa (Fig. 4A, lane 2), which was absent 
from the mock precipitation without anti-pATH52 (lane 1). 
The 23 kDa species immunoprecipitated using an anti-MTase 
antibody had the same mobility as that of p23 in whole MEL 
nuclear extracts, as judged by Western blot analysis (Fig. 4B). 
Reciprocal immunoprecipitation with anti-p23 and Western 
blotting using anti-MTase also indicated the two proteins in- 
teract in MEL cell extracts (data not shown). A Myc-tagged 
mouse MTase was overproduced in COS cells and partially 
purified, this was then added to the MEL nuclear extract and 
precipitated using a monoclonal anti-Myc antibody 9El0 
(Fig. 4C). Again, the 23 kDa band appeared only in the 
9El0 precipitation lane but not in the mock lane without 
9El0. These results indicate that the MTase and p23 interact 
specifically in MEL cell extracts. 
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4. Discussion 
Here we have used the yeast two-hybrid assay to screen a 
fusion cDNA library for proteins that interact with the human 
MTase protein. Two regions of the MTase, the replication- 
targeting domain (bait I) and the region immediately N-term- 
inal to the catalytic domain (bait III), themselves activate 
reporter gene transcription when fused to the DNA-binding 
domain of LexA. We do not ascribe any biological signifi- 
cance to this finding, as many sequences possess the ability 
to stimulate transcription when linked to a DNA-binding do- 
main [26]. In particular, sequences rich in acidic residues can 
often function as activation domains; regions I and III of the 
human MTase have pls of 4.3 and 5.7, respectively. On the 
other hand, regions II and IV of the MTase are more basic 
(pls of 9.6 and 9.9, respectively), and lack the ability to acti- 
vate transcription. 
Two-hybrid screens using the Cys-rich domain of the 
MTase (bait II) failed to identify any interacting proteins. 
When a mutationally inactivated form of the C-terminal cat- 
alytic MTase domain was used as bait (bait IV), 10 positive 
interacting clones were obtained from the B42-cDNA fusion 
library after tertiary screening. All of these clones encoded the 
same B42 fusion partner, identified as the full-length product 
of the human p23 gene. The repeated isolation of a single 
strongly interacting partner from a library having a complex- 
ity of ,~ 106 argues that the human MTase C-terminal domain 
is not simply 'sticky', and suggests the MTase and p23 bind 
one another specifically in the yeast cell, where high concen- 
trations of non-specific ompetitor proteins are present. The 
results of in vitro binding assays demonstrate hat p23 is able 
to interact directly with the full-length MTase. 
At present, the functional role of the p23-MTase interac- 
tion is uncertain, p23 was originally cloned as a protein asso- 
ciating with the cytoplasmic ('untransformed') form of the 
progesterone r ceptor, in a complex containing several addi- 
A 
kDa 
216 - -  
116 - -  
76 
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p23 
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216- -  
116- -  
76 - -  
44 - -  
27 m 
4-  MTase-Myc  
4--  p23 .4-- p23 
18 18 m 
Fig. 4. Association of mouse MTase with p23 protein in MEL cell extracts. A: Immunoprecipitation of p23 with anti-MTase antibody (anti- 
pATH52). The complexes were analyzed on a 12% gel and silver-stained. Lane 1, mock immunoprecipitation without anti-pATH52; lane 2, im- 
mune isolation from MEL nuclear extracts with anti-pATH52. Positions of molecular weight markers are shown on the left. B: The p23 kDa 
species precipitated by an anti-MTase antibody is detected by anti-p23 (J J3). Lane 1, control ane showing immunoblotting of p23 from MEL 
cell nuclear extracts; lane 2, immunoblotting of p23 from the immunoprecipitated proteins isolated by anti-pATH52. C: Monoclonal antibody 
9El0 against Myc immunoprecipitates p23 from MEL nuclear extracts upplemented with Myc-tagged MTase. Lane 1, mock immunoprecipita- 
tion without antibody 9El0; lane 2, immune isolation with 9El0. Positions of molecular weight markers are shown on the left. 
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tional proteins [21]. It has been suggested that p23 is a com- 
ponent of several other cytoplasmic omplexes of steroid re- 
ceptor complexes [27,28]. p23 may also form complexes with 
the hsp90 in the absence of steroid hormone receptors; how- 
ever, unlike heat shock protein, p23 is not induced thermally 
[21,29]. p23 is known to be phosphorylated [21] in resting 
c~lls, but the role of the phosphorylation, if any, remains to 
b,~ determined. The function of p23 in the complexes it forms, 
o- in the cell as a whole, is unknown. Moreover, p23 lacks 
d scernible sequence similarity to any known proteins. Despite 
t6s  lack of information, it seems likely that p23 fulfills an 
e;sential functional role, as the protein is highly conserved 
t!troughout eukaryotes, and its sequence from birds through 
Lammals is close to invariant. 
The finding that p23 interacts with the C-terminal domain 
(.f the MTase suggests that p23 might modulate the catalytic 
a~tivity of the MTase. However, we were unable to detect any 
e~'ect of GST-p23 on the rate of transfer of radioactivity from 
[methyl-3H]S-adenosyl methionine to poly(dI-dC) [30,31], even 
when GST-p23 was present at relatively high concentrations 
(~tata not shown). Because the C-terminal domain is so large 
( -,, 60 kDa), it can readily be envisioned to present a binding 
s arface to p23 that lies outside the region involved in catalysis 
~,f the methyl transfer reaction. 
Prior to the present study, all known complexes of p23 were 
l~)calized in the cytoplasm. Because the MTase is present al- 
laost exclusively in the nucleus, its interaction with p23 would 
most likely take place in the nucleus. Indeed, we found that in 
MEL cells, p23 partitions almost equally between the nucleus 
and cytoplasm. Because p23 is known to associate with hsp90, 
which in turn binds actin filaments [32,33], it is tempting to 
,~peculate that p23 might recruit the MTase to the nuclear 
1 aatrix via hsp90. 
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